Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Over-The-Counter
  • 1.3.3 Prescription Medications
• 1.4 Market Segment by Application
  • 1.4.1 Global Anti-inflammatory Drugs Market Share by Application (2019-2025)
  • 1.4.2 Skin Rashes
  • 1.4.3 Chronic Arthritis
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-inflammatory Drugs Market Size
  • 2.1.1 Global Anti-inflammatory Drugs Revenue 2014-2025
  • 2.1.2 Global Anti-inflammatory Drugs Sales 2014-2025
• 2.2 Anti-inflammatory Drugs Growth Rate by Regions
  • 2.2.1 Global Anti-inflammatory Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Anti-inflammatory Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Anti-inflammatory Drugs Sales by Manufacturers
  • 3.1.1 Anti-inflammatory Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Anti-inflammatory Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Anti-inflammatory Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anti-inflammatory Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Anti-inflammatory Drugs Price by Manufacturers
• 3.4 Key Manufacturers Anti-inflammatory Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Anti-inflammatory Drugs Market
• 3.6 Key Manufacturers Anti-inflammatory Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Over-The-Counter Sales and Revenue (2014-2019)
  • 4.1.2 Prescription Medications Sales and Revenue (2014-2019)
• 4.2 Global Anti-inflammatory Drugs Sales Market Share by Type
• 4.3 Global Anti-inflammatory Drugs Revenue Market Share by Type
• 4.4 Anti-inflammatory Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Anti-inflammatory Drugs Sales by Application

6 United States

• 6.1 United States Anti-inflammatory Drugs Breakdown Data by Company
• 6.2 United States Anti-inflammatory Drugs Breakdown Data by Type
• 6.3 United States Anti-inflammatory Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Anti-inflammatory Drugs Breakdown Data by Company
• 7.2 European Union Anti-inflammatory Drugs Breakdown Data by Type
• 7.3 European Union Anti-inflammatory Drugs Breakdown Data by Application

8 China

• 8.1 China Anti-inflammatory Drugs Breakdown Data by Company
• 8.2 China Anti-inflammatory Drugs Breakdown Data by Type
• 8.3 China Anti-inflammatory Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Anti-inflammatory Drugs Breakdown Data by Company
• 9.2 Rest of World Anti-inflammatory Drugs Breakdown Data by Type
• 9.3 Rest of World Anti-inflammatory Drugs Breakdown Data by Application
• 9.4 Rest of World Anti-inflammatory Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Anti-inflammatory Drugs Sales by Countries
  • 9.4.2 Rest of World Anti-inflammatory Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Roche
  • 10.1.1 Roche Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.1.4 Anti-inflammatory Drugs Product Introduction
  • 10.1.5 Roche Recent Development
• 10.2 Abbott Laboratories
  • 10.2.1 Abbott Laboratories Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.2.4 Anti-inflammatory Drugs Product Introduction
  • 10.2.5 Abbott Laboratories Recent Development
• 10.3 Johnson & Johnson
  • 10.3.1 Johnson & Johnson Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.3.4 Anti-inflammatory Drugs Product Introduction
  • 10.3.5 Johnson & Johnson Recent Development
• 10.4 Merck & Co.
  • 10.4.1 Merck & Co. Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.4.4 Anti-inflammatory Drugs Product Introduction
  • 10.4.5 Merck & Co. Recent Development
• 10.5 Pfizer
  • 10.5.1 Pfizer Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.5.4 Anti-inflammatory Drugs Product Introduction
  • 10.5.5 Pfizer Recent Development
• 10.6 Amgen
  • 10.6.1 Amgen Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.6.4 Anti-inflammatory Drugs Product Introduction
  • 10.6.5 Amgen Recent Development
• 10.7 Sanofi
  • 10.7.1 Sanofi Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.7.4 Anti-inflammatory Drugs Product Introduction
  • 10.7.5 Sanofi Recent Development
• 10.8 Novartis
  • 10.8.1 Novartis Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.8.4 Anti-inflammatory Drugs Product Introduction
  • 10.8.5 Novartis Recent Development
• 10.9 Eli Lilly
  • 10.9.1 Eli Lilly Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.9.4 Anti-inflammatory Drugs Product Introduction
  • 10.9.5 Eli Lilly Recent Development
• 10.10 Amgen
  • 10.10.1 Amgen Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Anti-inflammatory Drugs
  • 10.10.4 Anti-inflammatory Drugs Product Introduction
  • 10.10.5 Amgen Recent Development
• 10.11 Bayer
• 10.12 Novacap
• 10.13 Kopran Ltd.

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Anti-inflammatory Drugs Sales Channels
  • 11.2.2 Anti-inflammatory Drugs Distributors
• 11.3 Anti-inflammatory Drugs Customers

12 Market Forecast

• 12.1 Global Anti-inflammatory Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Anti-inflammatory Drugs Sales Forecast by Type
• 12.3 Global Anti-inflammatory Drugs Sales Forecast by Application
• 12.4 Anti-inflammatory Drugs Forecast by Regions
  • 12.4.1 Global Anti-inflammatory Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Anti-inflammatory Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Anti-inflammatory Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-inflammatory Drugs.

This report studies the global market size of Anti-inflammatory Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-inflammatory Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Bayer
Novacap
Kopran Ltd.

Market Segment by Product Type
Over-The-Counter
Prescription Medications

Market Segment by Application
Skin Rashes
Chronic Arthritis
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anti-inflammatory Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-inflammatory Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-inflammatory Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025